Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
41 studies found for:    Open Studies | "Tinnitus"
Show Display Options
Rank Status Study
21 Recruiting Pilot Study of Deep Brain Stimulation (DBS) in Area LC for Chronic Tinnitus
Condition: Tinnitus
Intervention: Device: Deep Brain Stimulation (DBS)
22 Not yet recruiting Deep TMS of the Left Auditory Cortex Using the HMCIPCC Coil, in the Treatment of Patients With Tinnitus.
Condition: Tinnitus
Intervention: Device: Deep Transcranial Magnetic Stimulation
23 Not yet recruiting Acoustic Stimulation Paired With Body and Cortical Stimulation for Modulating Tinnitus
Condition: Tinnitus
Interventions: Device: noise sound stimulation (Tucker-Davis Technologies);   Device: body electrical stimulation (Digitimer device);   Device: transcranial magnetic stimulation (Magstim)
24 Recruiting Research Project About Psychological Strain, Quality of Life and Emotional Awareness in Patients With Tinnitus
Condition: Tinnitus
Intervention: Other: observational research
25 Recruiting The Effect of Transcranial Direct Current Stimulation (tDCS) in Addition to Tinnitus Retraining Therapy (TRT) for Treatment of Chronic Tinnitus Patients
Condition: Tinnitus
Intervention: Device: transcranial direct current stimulation (tDCS)
26 Recruiting A Comparison of the Benefits of Mindfulness Based Cognitive Therapy, Relaxation Therapy and a Waiting List Control in the Management of Distress in Chronic Tinnitus Patients
Condition: Tinnitus
Interventions: Other: No treatment waiting period;   Behavioral: Mindfulness Based Cognitive Therapy;   Behavioral: Relaxation Therapy
27 Recruiting Combined Transcranial and Peripheral Muscle Magnetic Stimulation in Chronic Tinnitus
Condition: Chronic Tinnitus
Intervention: Device: rPMS and rTMS
28 Recruiting Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo
Condition: Tinnitus, Subjective
Interventions: Drug: AUT00063;   Drug: Placebo
29 Recruiting Therapeutic Effect of Repetitive Transcranial Magnetic Stimulaton on Tinnitus
Condition: Patients With Subjective Tinnitus
Interventions: Device: real repetitive Transcranial Magnetic Stimulation;   Device: sham repetitive Transcranial Magnetic Stimulation
30 Not yet recruiting Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
Condition: Tinnitus
Interventions: Drug: Ginkgo biloba;   Behavioral: modified tinnitus retraining therapy (TRT)
31 Not yet recruiting Inhibitor Masking Device & SCN9 Gene Expression
Condition: Tinnitus
Intervention: Device: The Inhibitor™  Tinnitus Masking Device
32 Not yet recruiting Cognitive Behavioral Therapy and Coping Effectiveness Training
Condition: Tinnitus
Interventions: Behavioral: Coping Effectiveness Training (CET) for tinnitus;   Behavioral: Cognitive-behavioral therapy (CBT)
33 Recruiting The Effect of Coenzyme Q10 on Hearing and Tinnitus Characteristics of Chronic Tinnitus Patients: a Double-blinded Randomized Trial.
Condition: Tinnitus
Interventions: Dietary Supplement: Q10;   Dietary Supplement: placebo
34 Recruiting Effect of Time Shift of Transcranial Direct Current Stimulation (tDCS) for Treatment of Acute Tinnitus
Condition: Tinnitus
Intervention: Other: transcranial direct current stimulation (tDCS)
35 Not yet recruiting SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Conditions: Lung Cancer;   Head and Neck Cancer;   Hearing Loss;   Ototoxicity;   Tinnitus;   Neuropathy
Interventions: Drug: SPI-1005 Low Dose;   Drug: SPI-1005 Middle Dose;   Drug: SPI-1005 High Dose;   Drug: Placebo
36 Recruiting Hearing Health Care Service Access and Use
Conditions: Hearing Loss;   Tinnitus
Interventions: Other: Screening;   Other: Brochure;   Behavioral: Education
37 Recruiting Prevention of Noise-induced Damage by Use of Antioxidants
Conditions: Noise-induced Tinnitus;   Noise-induced Hearing Loss
Intervention: Drug: Antioxidantia
38 Recruiting Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Condition: Idiopathic Intracranial Hypertension
Intervention: Drug: AZD4017
39 Not yet recruiting Cochlear Implantation in Single Sided Deafness and Asymmetrical Hearing Loss: a Cost/Utility Study.
Conditions: Retrocochlear Pathology;   Auditory Processing Disorder, Central;   Major Cochlear Ossification or Malformation
Interventions: Device: cochlear implantation;   Other: 6 months initial abstention
40 Recruiting Phase 3 Clinical Trial: D-Methionine to Reduce Noise-Induced Hearing Loss (NIHL)
Condition: Noise-Induced Hearing Loss
Interventions: Drug: D-methionine, oral liquid suspension;   Other: Placebo Comparator

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years